Cutibacterium Acnes, Prosthetic-joint Infection, Surgery, Surgical Site Infection
Conditions
Keywords
Antimicrobial wound gel, SURGX, Betadine, Dermal layer, Skin preparation
Brief summary
Comparing the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus antimicrobial wound gel versus betadine applied to the skin layer after the skin incision has been made. Reducing the bacteria present in the deep tissues at the end of the surgery may prevent infections from developing in the future.
Detailed description
Cutibacterium acnes (C. acnes) prosthetic joint infection is a devastating and somewhat unique complication to shoulder arthroplasty. It is a very slow-growing, aerotolerant anaerobic, non-spore forming, gram-positive rod-shaped bacteria that takes up to 2-3 weeks to grow in a lab setting. There have been several studies assessing various agents in the fight to prevent C. acnes prosthetic joint infection. These agents include standard peri-operative measures typically taken when performing shoulder replacement surgery - pre-operative prophylactic antibiotics, pre-operative skin cleanse/wash, topical adjuvants (povidone-iodine, chlorhexidine, etc.), and intra-operative antibiotic powders. The overall infection rate of shoulder arthroplasty has been cited to be between 0.9-2.9%, with C. acnes being the most common bacterium in shoulder arthroplasty periprosthetic infections. Morbidity and cost associated with shoulder prosthetic joint infection is extremely high, requiring multiple surgeries and months of treatment to overcome the infection. One of the main issues with C. acnes is its preferred location within the body, residing within the sebaceous glands of the hair follicles, deep to the epidermis where many preoperative topical preparations to cleanse the skin prior to surgery have little affect. These glands are commonly found around the shoulder and upper back, and lead to acne. C. acnes, along with other common prosthetic joint infection bacteria, quickly create a biofilm which is impenetrable to most antibiotic agents, further stressing the importance of prevention. Recently there have been studies analyzing the effects of Benzoyl Peroxide (BPO) on C. acnes as it relates to shoulder arthroplasty in an attempt to reduce this bacterial burden prior to surgery. There have been promising results with multi-day preparation skin cleansing with benzoyl peroxide. However, there are no studies looking at intra-operative skin incision preparations targeting the region of skin where the C. acnes bacteria resides. In vitro studies show SURGX antimicrobial gel (Next Science, Jacksonville, FL) results in a marked reduction of C. acnes in addition to other common bacteria affecting prosthetic joints. This gel uses citric acid to chelate the metallic bonds of biofilm. The bacteria are then destroyed by a combination of a high osmolarity environment coupled with a surfactant. The first purpose of the study is to evaluate if a dermal layer preparation will reduce positive cultures of C. acnes after primary shoulder arthroplasty. There will be a control group consisting of no skin preparation. There will be two additional comparative groups. The second purpose of this study is to compare the use of standard povidone-iodine swab versus SURGX antimicrobial gel as an application into the dermal layer after the skin incision has been made with a skin knife to see if there is a reduction in bacterial burden in the superficial and deep tissues at the end of a primary shoulder arthroplasty. Superficial and deep cultures will be obtained at the conclusion of the shoulder replacement surgery. These cultures will be held in the lab for 2 weeks to identify if bacteria is present. The study team's hypothesis is that the SURGX antimicrobial gel will provide a greater reduction in bacterial burden compared to povidone-iodine within the deep tissues after primary shoulder arthroplasty.
Interventions
Applied to skin incision.
Applied to skin incision.
Sponsors
Study design
Intervention model description
This is a prospective clinical trial in which patients will be assigned a study arm in sequential fashion.
Eligibility
Inclusion criteria
* Patient is planned to undergo elective primary anatomic or reverse shoulder arthroplasty.
Exclusion criteria
* Patient is undergoing revision shoulder replacement surgery. * Patient has a known allergy to iodine, benzalkonium chloride, or polythylene glycol.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | Day 14 | Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of patients with at least one positive culture were compared among the three study arms. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep | Day 14 | Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of baceria. The number of patients with at least one positive culture were compared among the SURGX and povidone-iodine groups. |
Countries
United States
Participant flow
Recruitment details
Participants were recruited by physicians at 1 academic medical center between June 2023 and November 2023.
Pre-assignment details
60 participants were enrolled, and all 60 met inclusion criteria and were randomized to a study arm.
Participants by arm
| Arm | Count |
|---|---|
| No Skin Incision Preparation The control group will receive no dermal layer skin preparation. At the time of the surgery, after the skin incision has been made with a skin knife, the dermal layer will not be prepped with an agent. | 20 |
| Povidone-iodine At the time of the surgery, after the skin incision has been made, the dermal layer will be prepped with povidone-iodine.
Drug: povidone-iodine Dose: swabstick Administration: swab the incision Frequency: once
Povidone-Iodine: Applied to skin incision. | 20 |
| SURGX Wound Gel At the time of the surgery, after the skin incision has been made, the dermal layer will be prepped with SURGX Wound Gel. SURGX wound gel is a topical antiseptic gel agent to be used on surgical incisions to prevent bacterial infection.
SURGX Wound Gel: Applied to skin incision. | 20 |
| Total | 60 |
Baseline characteristics
| Characteristic | No Skin Incision Preparation | Povidone-iodine | SURGX Wound Gel | Total |
|---|---|---|---|---|
| Age, Continuous | 69.35 years STANDARD_DEVIATION 8.443 | 68.50 years STANDARD_DEVIATION 10.405 | 68.75 years STANDARD_DEVIATION 7.107 | 68.87 years STANDARD_DEVIATION 8.615 |
| BMI | 29.1880 kg/m2 STANDARD_DEVIATION 7.22953 | 32.5010 kg/m2 STANDARD_DEVIATION 5.58499 | 30.7310 kg/m2 STANDARD_DEVIATION 6.53229 | 30.8067 kg/m2 STANDARD_DEVIATION 6.51775 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 18 Participants | 20 Participants | 18 Participants | 56 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 2 Participants | 0 Participants | 2 Participants | 4 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 1 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants | 1 Participants | 1 Participants | 3 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 2 Participants | 1 Participants | 1 Participants | 4 Participants |
| Race (NIH/OMB) White | 16 Participants | 18 Participants | 18 Participants | 52 Participants |
| Sex: Female, Male Female | 10 Participants | 14 Participants | 15 Participants | 39 Participants |
| Sex: Female, Male Male | 10 Participants | 6 Participants | 5 Participants | 21 Participants |
| Type of Shoulder Arthroplasty Anatomic TSA | 3 Participants | 1 Participants | 3 Participants | 7 Participants |
| Type of Shoulder Arthroplasty Reverse TSA | 17 Participants | 19 Participants | 17 Participants | 53 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk |
|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 20 | 1 / 20 | 0 / 20 |
| other Total, other adverse events | 0 / 20 | 0 / 20 | 0 / 20 |
| serious Total, serious adverse events | 2 / 20 | 3 / 20 | 2 / 20 |
Outcome results
Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep
Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of patients with at least one positive culture were compared among the three study arms.
Time frame: Day 14
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Skin Incision Preparation | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 11 Participants |
| Povidone-iodine | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 9 Participants |
| SURGX Wound Gel | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 6 Participants |
Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep
Each participant had 5 total culture swabs at end of surgical case from deep (2), superficial (2), and implant (1) locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of positive cultures after 2 weeks were compared among the control group and SURGX group.
Time frame: Day 14
Population: Each participant had 5 total culture swabs at end of shoulder surgery from deep (2), superficial (2), and implant (1) locations.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| No Skin Incision Preparation | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 29 # of positive cultures |
| Povidone-iodine | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 24 # of positive cultures |
| SURGX Wound Gel | Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep | 13 # of positive cultures |
Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep
Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of baceria. The number of patients with at least one positive culture were compared among the SURGX and povidone-iodine groups.
Time frame: Day 14
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| No Skin Incision Preparation | Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep | 11 Participants |
| Povidone-iodine | Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep | 9 Participants |
| SURGX Wound Gel | Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep | 6 Participants |